EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes

Ivonne Bedei iD, Johanna Bruder, Ida C B Lund iD, Simon H Thomsen iD, Ida Vogel iD, Andrea T Maciel-Guerra iD, Francisco Alvarez-Nava iD, Melissa L Crenshaw iD, Roland Axt-Fliedner, Claus H Gravholt iD, Anne Skakkebæk iD

American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2025-06 · 199 (2) · 124-133

DOI: 10.1002/ajmg.c.32136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 05.03.2025. Verfasst von Ivonne Bedei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University, Gießen, Germany. Hauptthemen laut MEDLINE: Turner Syndrome, Mosaicism, Cell-Free Nucleic Acids, Noninvasive Prenatal Testing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Independent Research Fund Denmark,, Sygesikringen Danmark, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Turner Syndrome (TS) is a sex chromosomal disorder associated with karyotype heterogeneity. Although TS can be associated with severe prenatal findings, most often linked to the 45, X karyotype, the majority of TS fetuses have no overt phenotype, resulting in delayed diagnosis and management. The objective of this study is to assess the efficacy of non‐invasive prenatal testing by cell‐free DNA (cfNIPT) in detecting TS fetuses with different TS karyotype variants and to examine the phenotypic variations and clinical outcomes.Data on pregnancies with confirmed or suspected TS from 2000 to 2024 were collected from specialists in fetal ultrasound in Germany. In addition, a small number of Danish cases with 45, X mosaicism in the placenta was included. Data were collected regarding cfNIPT results, karyotypes, prenatal ultrasound findings, and pregnancy outcomes.Of the 114 cases included, 100 (87.7%) had a high‐risk cfNIPT result for monosomy X, 53 (46.5%) were true positives (TP), and 47 (41.2%) were false positives (FP). Fourteen (12.3%) were false negatives (FN). No differences in congenital malformation or nuchal translucency were seen between TP and FN. Data on karyotype were available for 67 cases. Fourty (59.7%) had a 45, X karyotype, 16 (23.9%) 45, X mosaicism, and 11 (16.4%) had a structural variant. The 45, X karyotype was associated with a higher prevalence of congenital malformation and increased nuchal translucency (ps ≤ 0.001). The live birth rate was higher in cases with 45, X mosaicism or structural variants compared to cases with a 45, X karyotype (ps ≤ 0.03). Postnatal phenotypes were often mild.cfNIPT represents a valuable tool for the early identification of fetuses with TS karyotype variants, enabling timely intervention and targeted management. However, the high false‐positive rate underscores the need for careful counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Turner SyndromeMosaicismCell-Free Nucleic AcidsNoninvasive Prenatal TestingPrenatal DiagnosisHumansFemalePregnancyAdultPregnancy OutcomeKaryotypingPhenotypeUltrasonography, PrenatalGenetic Testing

Stichwörter der Autor:innen

Turner syndromeTurner syndrome mosaicismcfNIPTprenatal phenotypestructural variant

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University, Gießen, Germany.
  • Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Department of Clinical Medicine, Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
  • Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Ivonne Bedei, Ida C B Lund, Simon H Thomsen, Ida Vogel, Andrea T Maciel-Guerra, Francisco Alvarez-Nava, Melissa L Crenshaw, Claus H Gravholt, Anne Skakkebæk

Förderung

  • the Independent Research Fund Denmark,
  • Sygesikringen Danmark
  • Novo Nordisk Fonden

Zitieren

APA

Bedei, I., Bruder, J., Lund, I. C. B., Thomsen, S. H., Vogel, I., Maciel-Guerra, A. T., Alvarez-Nava, F., Crenshaw, M. L., Axt-Fliedner, R., Gravholt, C. H., & Skakkebæk, A. (2025). Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 199(2), 124-133. https://doi.org/10.1002/ajmg.c.32136

Vancouver

Bedei I, Bruder J, Lund ICB, Thomsen SH, Vogel I, Maciel-Guerra AT, et al. Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2025;199(2):124-133. doi:10.1002/ajmg.c.32136

BibTeX
@article{Bedei2025,
  author = {Bedei, Ivonne and Bruder, Johanna and Lund, Ida C B and Thomsen, Simon H and Vogel, Ida and Maciel-Guerra, Andrea T and Alvarez-Nava, Francisco and Crenshaw, Melissa L and Axt-Fliedner, Roland and Gravholt, Claus H and Skakkebæk, Anne},
  title = {Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2025},
  volume = {199},
  number = {2},
  pages = {124--133},
  doi = {10.1002/ajmg.c.32136}
}
Kostenlos starten →